This announcement is a separate document:
华兰生物：华泰联合证券有限责任公司关于华兰生物工程股份有限公司分拆所属子公司华兰生物疫苗股份有限公司至创业板上市之持续督导意见
Hualan Biotech: Huatai United Securities Co., Ltd.\'s continuing supervisory opinions on the spin-off of Hualan Bioengineering Co., Ltd.\'s subsidiary Hualan Biovaccine Co., Ltd. until listing on the GEM
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.